Hormonal therapy for male breast cancer: A different approach for a different disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Treatment Reviews

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CTRV.2005.12.007PMID 16472925
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast Cancer in Men

  2017cited by this paper
• Cancer Management: A Multidisciplinary Approach

  2007cited by this paper
• Epidemiology of male breast cancer.

  2005cited by this paper
• Successful use of letrozole in male breast cancer: A case report and review of hormonal therapy for male breast cancer

  2005cited by this paper
• Breast carcinoma in men

  2004cited by this paper
• Rémission complète par létrozole chez un homme traité pour un cancer du sein métastatique

  2004cited by this paper
• [Complete remission obtained with letrozole in a man with metastatic breast cancer].

  2004cited by this paper
• Is Male Breast Cancer Similar or Different than Female Breast Cancer?

  2004cited by this paper
• Male versus female breast cancers. A population-based comparative immunohistochemical analysis.

  2003cited by this paper
• Male breast cancer

  2003cited by this paper
• Breast Cancer in Men

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.

  2002cited by this paper
• 19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT

  2002cited by this paper
• Male Breast Carcinoma: Correlation of ER, PR, Ki-67, Her2-Neu, and p53 with Treatment and Survival, a Study of 65 Cases

  2002cited by this paper
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

  2002cited by this paper
• Efficacy of Anastrozole in Male Breast Cancer

  2002cited by this paper
• Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.

  2001cited by this paper
• Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility.

  2000cited by this paper
• The CAG repeat within the androgen receptor gene in male breast cancer patients

  2000cited by this paper
• Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.

  2000cited by this paper
• Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.

  2000cited by this paper
• Male breast carcinoma

  1999cited by this paper
• Proliferative activity and steroid hormone receptor status in male breast carcinoma.

  1998cited by this paper
• Molecular markers in male breast carcinoma

  1998cited by this paper
• Landfills: is wetter better?

  1998cited by this paper
• Effect of long-term treatment with aromatase inhibitor on testicular function of adult male bonnet monkeys (M. radiata).

  1998cited by this paper
• Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

  1998cited by this paper
• No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.

  1998cited by this paper
• Carcinoma of the breast in males

  1998cited by this paper
• Sex differences in androgen-regulated expression of cytochrome P450 aromatase in the rat brain.

  1997cited by this paper
• A review of the management of the male breast carcinoma based on an analysis of 420 treated cases

  1996cited by this paper
• The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor.

  1996cited by this paper
• Breast cancer in men.

  1996cited by this paper
• Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas.

  1996cited by this paper
• Male breast cancer: results of the treatments and prognostic factors in 397 cases.

  1995cited by this paper
• A 50-year experience of male breast cancer: is outcome changing?

  1993cited by this paper
• The Breast Cancer Screening Controversy Continues

  1993cited by this paper
• Adjuvant tamoxifen for male breast cancer (MBC).

  1992cited by this paper
• Advanced male breast cancer treatment with the LH‐RH analogue buserelin alone or in combination with the antiandrogen flutamide

  1988cited by this paper
• Aromatase inhibition in the dog. I. Effect on serum LH, serum testosterone concentrations, testicular secretions and spermatogenesis.

  1988cited by this paper
• Nasally administered buserelin inducing complete remission of lung metastases in male breast Cancer

  1987cited by this paper
• Hormonal treatment of disseminated male breast cancer.

  1985cited by this paper
• Metastatic breast cancer in males assessment of endocrine therapy

  1984cited by this paper
• Inhibition of aromatization stimulates luteinizing hormone and testosterone secretion in adult male rhesus monkeys.

  1984cited by this paper
• Hormonal Therapy for Metastatic Male Breast Cancer

  1983cited by this paper
• Hormonal therapy for metastatic male breast cancer.

  1983cited by this paper
• Tamoxifen in the treatment of male breast carcinoma.

  1983cited by this paper
• Cyproterone acetate in advanced male breast cancer.

  1982cited by this paper
• High-dose medroxyprogesterone acetate in advanced male breast cancer.

  1982cited by this paper
• Cyproterone acetate in advanced male breast cancer

  1982cited by this paper
• Diabetes control and neuropathy.

  1981cited by this paper
• Use of tamoxifen in advanced male breast cancer.

  1980cited by this paper
• Use of tamoxifen in advanced male breast cancer.

  1980cited by this paper
• Breast cancer in the male: A report of 138 cases

  1980cited by this paper
• Male Breast Cancer: A Clinicopathologic Study of 97 Cases

  1978cited by this paper
• The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast.

  1976cited by this paper
• EFFECT OF ORCHIDECTOMY ON SKELETAL METASTASES FROM CANCER OF THE MALE BREAST.

  1942cited by this paper
• CANCER OF THE BREAST

  1941cited by this paper
• © 1999 Cancer Research Campaign Article no. bjoc.1999.0663 Short Communication

  year unknowncited by this paper

• Primary Male Neuroendocrine Breast Carcinoma: A Case Report and Review of Literature

  2025cites this paper
• Male Breast: A Review of the Literature and Current State of the Art of Diagnostic Imaging Work-Up

  2023influential citation
• The Significance Of Hormone Receptors In Male Breast Cancer

  2020cites this paper
• Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance.

  2018cites this paper
• Proximal shift of colorectal cancer with increasing age in different ethnicities

  2018cites this paper
• Metastatic Breast Carcinoma to the Superior Oblique in a Male

  2017cites this paper
• Molecular subtypes of male breast cancer by immunohistochemistry

  2017cites this paper
• CT-guided percutaneous laser ablation of metastatic lung cancer: three cases report and literature review

  2016cites this paper
• FORMACIÓN CONTINUADA: ACTUALIZACIÓN EN MEDICINA Actualización del cáncer de mama en atención primaria (V/V)

  2016cites this paper
• Male Breast Cancer.

  2016cites this paper
• Pelvic Imaging using Sonography and Hysterosonography in the Female Patient

  2016cites this paper
• Male Breast Cancer

  2016cites this paper
• The Clinical Significance of Both IgM and IgG Anticardiolipin Antibodies in Non-Hodgkins Lymphoma

  2016cites this paper
• Immunocytochemical staining of cervical smears – A comparative study with routine cytology for confirmation of precancerous and cancerous lesions of cervix

  2016cites this paper
• Cáncer de mama en el hombre

  2016cites this paper
• Male breast cancer: Medical and psychological management in comparison to female breast cancer. A review

  2016cites this paper
• Рак молочной железы у мужчин при первично-множественных злокачественных опухолях

  2015cites this paper
• Male breast carcinoma: radiotherapy contributed to favorable local control in two cases and related literature review

  2015influential citation
• [Breast cancer update in primary care: (V/V)].

  2015cites this paper
• Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.

  2015cites this paper
• Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches

  2014cites this paper
• The Role of Adjuvant Radiation in High Risk Early-Stage Endometrial Cancer

  2014cites this paper
• Quantum Computing Based Technique for Cancer Disease Detection

  2014cites this paper
• Quantum Computing Based Technique for Cancer Disease Detection System

  2014cites this paper
• The Effect of Antineoplastic Drugs in a Male Spontaneous Mammary Tumor Model

  2013cites this paper
• Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences.

  2013cites this paper
• New approaches in the management of male breast cancer.

  2013influential citation
• Genotyping and Phenotyping of Male Breast Cancer

  2012cites this paper
• Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?!

  2012cites this paper
• Male breast carcinoma: epidemiology, risk factors and current therapeutic approaches.

  2012cites this paper
• Male breast cancer: treatment options

  2012cites this paper
• The Possible role of STAMP 1 in Breast Cancer Cell Proliferation

  2011cites this paper
• Similarities and differences in the characteristics and primary treatment of breast cancer in men and women – a population based study (Sweden)

  2011cites this paper
• High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

  2011cites this paper
• Male breast cancer

  2011cites this paper
• Management of male breast cancer

  2011influential citation
• Cancer du sein: l’homme est aussi concerné. Étude de 21 cas

  2011cites this paper
• Chinese female breast cancer patients show a better overall survival than their male counterparts.

  2010cites this paper
• Male breast cancer.

  2010cites this paper
• Characteristics of Chinese male patients with breast cancer: summary of the published papers

  2010cites this paper
• Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors.

  2010cites this paper
• Breast Diseases in Males

  2010cites this paper
• [Male breast cancer: a review].

  2009cites this paper
• Pharmacologic treatment of male breast cancer

  2009cites this paper
• Prolactin receptor expression in gynaecomastia and male breast carcinoma

  2008cites this paper
• Changes in Male Breast Cancer over a 30-Year Period

  2008cites this paper
• Understanding and management of male breast cancer: a critical review

  2008cites this paper
• Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.

  2008cites this paper
• Male Breast Cancer

  2008cites this paper
• Male breast cancer: Progress, prognosis and future pathways

  2008cites this paper
• Diagnosis and Management of Male Breast Cancer

  2008influential citation
• Male breast cancer after heart transplantation: a Case Study from The University of California, San Francisco

  2008cites this paper
• Prolactin Drives Estrogen Receptor-α-Dependent Ductal Expansion and Synergizes with Transforming Growth Factor-α to Induce Mammary Tumors in Males

  2008cites this paper
• Cáncer de seno: de la epidemiología al tratamiento

  2008cites this paper
• Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case report

  2008influential citation
• Case Study Male breast cancer after heart transplantation: a Case Study from The University of California, San Francisco

  2008cites this paper
• Breast cancer in men: should aromatase inhibitors become first-line hormonal treatment?

  2008cites this paper
• Bilateral Nonsynchronous Male Breast Cancer: Two Case Reports

  2008cites this paper
• Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray

  2007cites this paper
• An Unusual Case of Advanced Bilateral Male Breast Cancer

  2007cites this paper
• Male breast cancer in the veterans affairs population

  2007influential citation
• Some aspects of the endocrine profile and management of hormone-dependent male breast cancer.

  2007cites this paper
• Strategies in treating male breast cancer

  2007influential citation
• How to treat male breast cancer.

  2007cites this paper
• Male breast cancer: a review of clinical management

  2007cites this paper
• Endocrine Combination Therapy for Prostate and Metastatic Breast Cancer in a Male Patient

  2007cites this paper
• A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

  2007cites this paper
• How to treat male breast cancer.

  2007cites this paper
• World Journal of Surgical Oncology Open Access Bilateral Male Breast Cancer with Male Potential Hypogonadism

  year unknowncites this paper
• Oncotargets and Therapy Dovepress Dovepress Protein Tyrosine Phosphatase Shp-1 Sensitizes Egfr/her-2 Positive Breast Cancer Cells to Trastuzumab through Modulating Phosphorylation of Egfr and Her-2

  year unknowncites this paper